Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Timothy McAuliffe, Joseph C. Anderson, Robin J. Larson, Douglas J. Robertson |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Systematic Review: Use of Artificial Intelligence and Unmet Needs in Eosinophilic Oesophagitis
por: Ester Castagnaro, et al.
Publicado: (2025)
por: Ester Castagnaro, et al.
Publicado: (2025)
Systematic review: The use of large language models as medical chatbots in digestive diseases
por: Mauro Giuffrè, et al.
Publicado: (2024)
por: Mauro Giuffrè, et al.
Publicado: (2024)
Letter: Using non‐invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients
por: Wenjun Meng, et al.
Publicado: (2024)
por: Wenjun Meng, et al.
Publicado: (2024)
Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures
por: Raj Vuppalanchi, et al.
Publicado: (2024)
por: Raj Vuppalanchi, et al.
Publicado: (2024)
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
por: Léa Sequier, et al.
Publicado: (2024)
por: Léa Sequier, et al.
Publicado: (2024)
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
por: Cathy Lu, et al.
Publicado: (2024)
por: Cathy Lu, et al.
Publicado: (2024)
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
por: Annalisa Schiepatti, et al.
Publicado: (2024)
por: Annalisa Schiepatti, et al.
Publicado: (2024)
Letter: Reflections on the role of over‐the‐scope clips in high‐risk upper gastrointestinal bleeding
por: Yajie Wang, et al.
Publicado: (2024)
por: Yajie Wang, et al.
Publicado: (2024)
Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
por: Mohamad Jamalinia, et al.
Publicado: (2024)
por: Mohamad Jamalinia, et al.
Publicado: (2024)
Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
por: Joshua Reid, et al.
Publicado: (2024)
por: Joshua Reid, et al.
Publicado: (2024)
Letter: Over‐the‐scope clips in patients at high risk of re‐bleeding following upper gastrointestinal tract bleeding—The magic bullet for everyone?
por: Gabriel Allo, et al.
Publicado: (2024)
por: Gabriel Allo, et al.
Publicado: (2024)
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis
por: Claire A. Beveridge, et al.
Publicado: (2025)
por: Claire A. Beveridge, et al.
Publicado: (2025)
Letter: Over‐the‐scope clips in patients at high risk of rebleeding following upper gastrointestinal tract bleeding—The magic bullet for everyone? Authors'reply
por: Kai Song, et al.
Publicado: (2024)
por: Kai Song, et al.
Publicado: (2024)
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
por: Derek D. Satre, et al.
Publicado: (2024)
por: Derek D. Satre, et al.
Publicado: (2024)
Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies
por: Sarah Manning, et al.
Publicado: (2025)
por: Sarah Manning, et al.
Publicado: (2025)
Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom
por: Mohsin F. Butt, et al.
Publicado: (2025)
por: Mohsin F. Butt, et al.
Publicado: (2025)
The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population‐Based Study
por: Chachrit Khunsriraksakul, et al.
Publicado: (2025)
por: Chachrit Khunsriraksakul, et al.
Publicado: (2025)
Letter: Boosting non‐invasive tests—Opportunities and challenges from resmetirom
por: Gong Feng, et al.
Publicado: (2024)
por: Gong Feng, et al.
Publicado: (2024)
Systematic Review: Stigma Associated With Inflammatory Bowel Disease
por: Suprabhat Giri, et al.
Publicado: (2025)
por: Suprabhat Giri, et al.
Publicado: (2025)
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET‐NASH
por: Brent A. Neuschwander‐Tetri, et al.
Publicado: (2025)
por: Brent A. Neuschwander‐Tetri, et al.
Publicado: (2025)
Editorial: HDV Diagnosis Implementation: Gains in Systematic Screening, Gaps in Standardisation
por: Sara Battistella, et al.
Publicado: (2026)
por: Sara Battistella, et al.
Publicado: (2026)
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
por: Jeffrey D McCurdy, et al.
Publicado: (2025)
por: Jeffrey D McCurdy, et al.
Publicado: (2025)
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
por: Yewan Park, et al.
Publicado: (2024)
por: Yewan Park, et al.
Publicado: (2024)
Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence
por: Priyadarshini Zula, et al.
Publicado: (2026)
por: Priyadarshini Zula, et al.
Publicado: (2026)
Featured Cover
por: Erin R. Bonner, et al.
Publicado: (2025)
por: Erin R. Bonner, et al.
Publicado: (2025)
Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation
por: Erin R. Bonner, et al.
Publicado: (2025)
por: Erin R. Bonner, et al.
Publicado: (2025)
Systematic Review: Incidence of Liver‐Related Events in People Living With Hepatitis Delta Virus
por: Laura E. Telep, et al.
Publicado: (2025)
por: Laura E. Telep, et al.
Publicado: (2025)
Systematic Review: Imaging‐Based Morphological Criteria for Liver Cirrhosis—A Call to Standardise
por: Mei Chin Lim, et al.
Publicado: (2026)
por: Mei Chin Lim, et al.
Publicado: (2026)
Letter: From Safety to Precision—Optimising the Use of GLP‐1 Receptor Agonists in Gastroenterology
por: Joëlle St‐Pierre, et al.
Publicado: (2026)
por: Joëlle St‐Pierre, et al.
Publicado: (2026)
Some Risks of Gastrointestinal Adverse Events Associated With Glucagon‐Like PEPTIDE‐1 Receptor Agonists Are Likely Explained by BMI
por: Benjamin Douglas Liu, et al.
Publicado: (2025)
por: Benjamin Douglas Liu, et al.
Publicado: (2025)
Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
por: Tarek Hassanein, et al.
Publicado: (2024)
por: Tarek Hassanein, et al.
Publicado: (2024)
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
por: Jian Wang, et al.
Publicado: (2024)
por: Jian Wang, et al.
Publicado: (2024)
Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
por: Sara Massironi, et al.
Publicado: (2025)
por: Sara Massironi, et al.
Publicado: (2025)
Long‐Term Use of Fenofibrate as Second‐Line Therapy in Primary Biliary Cholangitis: A Retrospective Study
por: Mariko Maxwell, et al.
Publicado: (2026)
por: Mariko Maxwell, et al.
Publicado: (2026)
Chronic Use of Proton Pump Inhibitors Is Associated With Reduced 30‐Day Mortality From Acute Pancreatitis
por: Maya Fischman, et al.
Publicado: (2025)
por: Maya Fischman, et al.
Publicado: (2025)
Letter: Methodological Gaps Undermine Conclusions on Electronic Nose Use for Colorectal Cancer Detection—Authors' Reply
por: Milou. L. M. van Riswijk, et al.
Publicado: (2025)
por: Milou. L. M. van Riswijk, et al.
Publicado: (2025)
Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis
por: Bernardo de Faria Moraes, et al.
Publicado: (2026)
por: Bernardo de Faria Moraes, et al.
Publicado: (2026)
Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC
por: Naohiro Yasuura, et al.
Publicado: (2024)
por: Naohiro Yasuura, et al.
Publicado: (2024)
Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests?
por: C. Gaume, et al.
Publicado: (2024)
por: C. Gaume, et al.
Publicado: (2024)
Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease
por: DuJiang Yang, et al.
Publicado: (2025)
por: DuJiang Yang, et al.
Publicado: (2025)
Ejemplares similares
-
Systematic Review: Use of Artificial Intelligence and Unmet Needs in Eosinophilic Oesophagitis
por: Ester Castagnaro, et al.
Publicado: (2025) -
Systematic review: The use of large language models as medical chatbots in digestive diseases
por: Mauro Giuffrè, et al.
Publicado: (2024) -
Letter: Using non‐invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients
por: Wenjun Meng, et al.
Publicado: (2024) -
Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures
por: Raj Vuppalanchi, et al.
Publicado: (2024) -
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
por: Léa Sequier, et al.
Publicado: (2024)